Published in J Infect Dis on July 01, 1985
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol (1972) 6.33
Isolation of novel virus-like sequences associated with human hepatitis. Nat Med (1995) 4.99
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology (1994) 4.77
Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol (1970) 3.84
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol (1996) 2.98
HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81
Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76
Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology (1995) 2.73
Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol (1993) 2.50
Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol (1995) 2.38
Genetic heterogeneity of hepatitis E virus. J Med Virol (2001) 2.29
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol (1998) 2.22
Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis (1999) 2.21
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Transmission of hepatitis B virus by HBV-negative blood transfusion. Lancet (1995) 2.06
Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med (1979) 2.03
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol (1992) 1.94
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods (1992) 1.85
Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83
A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol (1999) 1.83
Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82
A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen. JAMA (1975) 1.78
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J Med Virol (1999) 1.77
Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J Clin Microbiol (1997) 1.76
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
TestPack Chlamydia, a new rapid assay for the direct detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.71
Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol (2000) 1.63
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. Cytometry (2000) 1.63
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology (1985) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol (1999) 1.59
An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol (2000) 1.58
Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol (1999) 1.57
DNA probe amplification methods. J Virol Methods (1992) 1.55
Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54
Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53
The mixed haemadsorption test as an aid to the diagnosis of thyroid autoimmune disease. Clin Exp Immunol (1968) 1.52
Homotypic echoviruses share aminoterminal VP1 sequence homology applicable for typing. J Med Virol (2001) 1.50
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48
Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol (1996) 1.46
Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods (2003) 1.45
Amplification and subtraction methods and their application to the discovery of novel human viruses. J Med Virol (1997) 1.44
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41
Identification of a novel variant of hepatitis E virus in Italy. J Med Virol (1999) 1.40
Predictors of GBV-C infection among patients referred for renal transplantation. Kidney Int (1998) 1.39
Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods (1998) 1.39
T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun (1983) 1.37
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37
Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol (1992) 1.37
Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36
Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses (1996) 1.36
Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol (1996) 1.35
Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.34
Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology (1996) 1.34
Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol (1999) 1.34
Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant. J Med Virol (1997) 1.33
Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A (1996) 1.32
Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31
Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS (1997) 1.31
Rapid detection of Hepatitis E virus RNA by reverse transcription-polymerase chain reaction using universal oligonucleotide primers. J Virol Methods (1999) 1.31
Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol (1996) 1.31
Immunological changes in primary HIV-1 infection. AIDS (1990) 1.30
Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer (1995) 1.29
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol (1996) 1.29
Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet (1992) 1.29
Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.28
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS (1998) 1.27
Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods (1996) 1.27
A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.27
Characterisation of a linear binding site for a monoclonal antibody to hepatitis B core antigen. J Med Virol (1991) 1.26
Prevalence of HIV-1 infection in the Kagera region of Tanzania: a population-based study. AIDS (1990) 1.26
Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg (1994) 1.26
An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis (1997) 1.24
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
The effect of irradiation on T-cell suppression of ELISA-determined Ig production by human blood B-cells in vitro. Clin Exp Immunol (1979) 1.22
Reaction of human smooth muscle antibody with thymus medullary cells. Nat New Biol (1973) 1.22
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A (1987) 1.21
Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences. J Virol (1997) 1.19
Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. AIDS (1999) 1.19